Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers

Objective: Romiplostim is used to treat chemotherapy-induced thrombocytopenia in a variety of tumor types; however, few studies have examined its use in breast and gynecologic cancers. We evaluated platelet response and durability of response to romiplostim in patients with gynecologic or breast can...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Gynecologic Oncology Reports
المؤلفون الرئيسيون:	Sara Moufarrij, Roisin E. O'Cearbhaill, Qin Zhou, Alexia Iasonos, Simon Mantha, Jeffrey Zwicker, Cy R. Wilkins
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-06-01
الموضوعات:	Romiplostim Chemotherapy-induced thrombocytopenia Gynecologic cancer Breast cancer
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S235257892400078X

مواد مشابهة

Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use
حسب: Cy R. Wilkins, وآخرون
منشور في: (2022-03-01)

Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study
حسب: Vikas Talreja, وآخرون

Total remission of severe immune thrombocytopenia after short term treatment with romiplostim
حسب: Efthymia Vlachaki, وآخرون
منشور في: (2011-10-01)

Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature
حسب: Gerald A. Soff, وآخرون
منشور في: (2024-08-01)

Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description
حسب: Rodriguez Nuñez Rosa María, وآخرون
منشور في: (2020-04-01)

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
حسب: I. A. Lisukov, وآخرون
منشور في: (2014-07-01)

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
حسب: I. A. Lisukov, وآخرون
منشور في: (2014-07-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
حسب: Alessandro Pecci, وآخرون
منشور في: (2017-11-01)

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
حسب: Francesca Palandri, وآخرون
منشور في: (2012-06-01)

Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use
حسب: Gilbert MM, وآخرون
منشور في: (2020-07-01)

Romiplostim for the Emergency Management of Severe Immune Thrombocytopenia with Intracerebral Hemorrhage
حسب: Romain Gellens, وآخرون
منشور في: (2018-01-01)

Missing Cells - A Rare Case of Persisting Thrombocytopenia in Pregnancy With Dengue and Role of Romiplostim in These Cases
حسب: Ruchita Sinha, وآخرون
منشور في: (2023-06-01)

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
حسب: Tremblay G, وآخرون
منشور في: (2018-11-01)

Multicenter Single‐Blind Randomized Controlled Trial of the Romiplostim Biosimilar
حسب: Anait L. Melikyan, وآخرون
منشور في: (2025-08-01)

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK
حسب: Nichola Cooper, وآخرون
منشور في: (2025-03-01)

Romiplostim-associated increase in CD34+ megakaryocytes in a case of immune thrombocytopenia: A case report
حسب: Charles M. Lombard, وآخرون
منشور في: (2023-06-01)

Clinical experience with romiplostim
حسب: G. B. Kuchma, وآخرون
منشور في: (2014-07-01)

Clinical experience with romiplostim
حسب: G. B. Kuchma, وآخرون
منشور في: (2014-07-01)

Romiplostim use for thrombocytopenia following allogeneic hematopoietic stem cell transplantation: a case series from a single center in Qatar
حسب: Abdulrahman F. Al-Mashdali, وآخرون
منشور في: (2023-12-01)

Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
حسب: Snigdha Nutalapati, وآخرون
منشور في: (2021-11-01)

Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?
حسب: Hanny Al-Samkari
منشور في: (2025-07-01)

Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis
حسب: Dorela Lame, وآخرون
منشور في: (2024-03-01)

Transient Leukoerythroblastosis Unmasking Clonal Hematopoiesis with Myelofibrosis in Refractory Thrombocytopenia
حسب: Giacomo Malipiero, وآخرون
منشور في: (2024-07-01)

Combination Therapy with Romiplostim, Danazol, and a Thrombopoietin Receptor Agonist for Immune Restoration in Chronic Refractory Immune Thrombocytopenia: A Case Series
حسب: Wang SX, وآخرون
منشور في: (2025-10-01)

Second‐line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records
حسب: Lincy S. Lal, وآخرون
منشور في: (2020-10-01)

Thrombocytopenia induced by clopidogrel: a rare adverse effect
حسب: Catarina Távora, وآخرون
منشور في: (2023-10-01)

Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia
حسب: Perdomo J
منشور في: (2016-02-01)

Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis
حسب: Xiaofang Zhang, وآخرون
منشور في: (2025-06-01)

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
حسب: Olga S. Levchenkova, وآخرون
منشور في: (2023-03-01)

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
حسب: O. Yu. Vinogradova, وآخرون
منشور في: (2024-12-01)

Management of patients with immune thrombocytopenia in the Moscow region
حسب: S. G. Zakharov, وآخرون
منشور في: (2022-11-01)

Urogenital haemorrhage secondary to Babesia gibsoni induced immune thrombocytopenia and its management with combination of romiplostim and prednisolone in a dog
حسب: Nadima Khan, وآخرون
منشور في: (2025-06-01)

Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?
حسب: Alexandra Schifferli, وآخرون
منشور في: (2019-06-01)

Experience of 2<sup>nd</sup> line therapy with eltrombopag in patients with immune thrombocytopenia
حسب: S. G. Zakharov, وآخرون
منشور في: (2023-09-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
حسب: Angelica Maria Garzon, وآخرون
منشور في: (2015-08-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
حسب: S. G. Zakharov, وآخرون
منشور في: (2024-04-01)

Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
حسب: Paschalis Evangelidis, وآخرون
منشور في: (2025-01-01)

Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice
حسب: II Zotova, وآخرون
منشور في: (2017-01-01)

Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently
حسب: Mohamed A. Yassin, وآخرون
منشور في: (2023-12-01)

A randomized, double‐blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers
حسب: Igor Makarenko, وآخرون
منشور في: (2023-10-01)